IntegraGen
Created in 2000
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
658 3,497Activities
Technologies
Entity types
Location
Campus 1, bâtiment 8, 5 Rue Henri Auguste Desbruères, 91030, France
Evry
France
Employees
Scale: 11-50
Estimated: 55
SIREN
432176543Engaged corporates
3
1 2Added in Motherbase
5 years, 11 months ago
deeptech Value proposition
Company specializing in the genomics of cancer and genetic diseases
IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of revenue in 2020. Based in France, IntegraGen is also present in the United States and is part of the OncoDNA group which works with an international network of 35 distributors. The Group also provides biomarker testing and clinical interpretation tools to guide treatment and monitoring of late stage solid tumors and accelerate the development of new cancer drugs. IntegraGen is listed on Euronext Growth in Paris (ISIN: FR0010908723 - Mnemo: ALINT - Eligible PEA-PME).
genetics, genotyping, sequencing, bioinformatics, precision medicine, NGS, genomics, oncology, and biomarkerOriginal language
Company specializing in the genomics of cancer and genetic diseases
IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of revenue in 2020. Based in France, IntegraGen is also present in the United States and is part of the OncoDNA group which works with an international network of 35 distributors. The Group also provides biomarker testing and clinical interpretation tools to guide treatment and monitoring of late stage solid tumors and accelerate the development of new cancer drugs. IntegraGen is listed on Euronext Growth in Paris (ISIN: FR0010908723 - Mnemo: ALINT - Eligible PEA-PME).
Home - Integragen
IntegraGen is an OncoDNA group company. It offers DNA sequencing services and genomic data interpretation software.
https://integragen.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Other 11 Jan 2024 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 11 Jan 2024 | | |
 Euronext Finance, Financial Services | Euronext Finance, Financial Services | Not capitalistic Not partnership Event 22 Nov 2014 | | |